Combination of a STAT3 Inhibitor and an mTOR Inhibitor Against a Temozolomide-resistant Glioblastoma Cell Line

Background: Temozolomide-resistant (TMZ-R) glioblastoma is very difficult to treat, and a novel approach to overcome resistance is needed. Materials and Methods: The efficacy of a combination treatment of STAT3 inhibitor, STX-0119, with rapamycin was investigated against our established TMZ-resistan...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Genomics Proteomics
Main Authors: MIYATA*, HARUO, ASHIZAWA*, TADASHI, IIZUKA, AKIRA, KONDOU, RYOTA, NONOMURA, CHIZU, SUGINO, TAKASHI, URAKAMI, KENICHI, ASAI, AKIRA, HAYASHI, NAKAMASA, MITSUYA, KOICHI, NAKASU, YOKO, YAMAGUCHI, KEN, AKIYAMA, YASUTO
Formato: Artigo
Idioma:Inglês
Publicado em: International Institute of Anticancer Research 2016
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5267503/
https://ncbi.nlm.nih.gov/pubmed/28031240
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados